Endocyte, Inc. (NASDAQ:ECYT)

CAPS Rating: 1 out of 5

Caps

How do you think ECYT will perform against the market?

Add Stock to CAPS Watchlist

All Players

96 Outperform
25 Underperform
 

All-Star Players

16 Outperform
13 Underperform
 

Wall Street

7 Outperform
0 Underperform
 

Top ECYT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Vandrebilt (< 20)
Submitted April 17, 2012

ECYT Will and has made millions of dollars and this is just the beginning. Unless they have an unseen setback with their drugs in the pipeline. My prediction is the stock quadruples x2

SkepBioInvestor (< 20)
Submitted February 25, 2014

No need to say more: http://www.thestreet.com/story/12441443/1/the-endocyte-bear-thesis-why-march-will-be-a-bad-month.html

ECYT VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ECYT.

Recs

0
Member Avatar clangmead (48.20) Submitted: 6/18/2018 8:57:40 PM : Outperform Start Price: $14.44 ECYT Score: +61.55

RACM

Recs

0
Member Avatar oscillation (79.38) Submitted: 12/31/2015 1:12:32 PM : Outperform Start Price: $4.02 ECYT Score: +449.13

nev

Recs

0
Member Avatar jtmeltzer (< 20) Submitted: 7/13/2015 9:21:23 PM : Outperform Start Price: $5.61 ECYT Score: +286.51

This company has some small drug conjugate chemotherapy modalities that could be the next big thing. Their small drug conjugates provide a novel way to introduce therapy inside a cancer cell. They have been incredibly close to a major breakthrough. Their cash on hand is worth about $4/sh. The stock values their patented technology worth $1.63/sh (about). Crazy. Look into this company further!

Leaderboard

Find the members with the highest scoring picks in ECYT.

Score Leader

tarikny500

tarikny500 (< 20) Score: +1,541.62

The Score Leader is the player with the highest score across all their picks in ECYT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tarikny500 < 20 8/1/2017 Outperform 5Y $1.42 +1,553.52% +11.90% +1,541.62 0 Comment
BOBBYLDc 62.61 10/2/2017 Outperform 5Y $1.65 +1,323.03% +10.10% +1,312.93 0 Comment
Reallynow222 97.61 3/22/2017 Outperform 5Y $2.19 +972.15% +18.45% +953.70 0 Comment
gunda7907 < 20 3/21/2017 Outperform 5Y $2.24 +948.17% +18.10% +930.07 0 Comment
sdhwang422 81.32 4/3/2017 Outperform 5Y $2.58 +810.08% +17.43% +792.65 0 Comment
portefeuille 98.51 2/10/2016 Outperform 5Y $2.95 +695.93% +47.49% +648.44 0 Comment
dasilook 25.23 1/13/2016 Outperform 5Y $2.99 +685.28% +46.62% +638.66 0 Comment
superstar2 99.50 7/6/2016 Outperform 5Y $3.19 +636.05% +32.28% +603.77 0 Comment
Playa15 < 20 1/21/2016 Outperform 5Y $3.33 +605.11% +47.64% +557.46 0 Comment
Wh0am1 < 20 12/21/2011 Outperform 3M $3.17 +640.69% +123.43% +517.26 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCantorFitz 34.49 9/9/2014 Outperform NS $7.28 +222.53% +38.17% +184.36 0 Comment
trackchardan 51.85 3/25/2014 Outperform NS $28.45 -17.47% +48.58% -66.04 0 Comment
TrackRothCapital 76.33 2/15/2013 Outperform NS $9.91 +136.93% +81.66% +55.28 0 Comment
TrackCreditSuiss 89.12 1/15/2013 Outperform NS $9.42 +149.26% +89.28% +59.98 0 Comment
TrackJimCramer 85.74 4/16/2012 Outperform 3W $7.62 +208.14% +102.04% +106.09 0 Comment
TrackRBCCapMkts 85.25 3/17/2011 Outperform NS $8.11 +189.52% +116.33% +73.19 0 Comment
TrackRWBaird 87.07 3/16/2011 Outperform NS $7.45 +215.17% +116.07% +99.09 0 Comment

Advertisement